5 completed, 2 not yet recruiting. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
Follow Inhalation anthrax: new trials by email Literature Review of Inhalation anthrax trials Research Report on Inhalation anthrax
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Clinical Benefit and Safety Following CYFENDUS Administration for Post-Exposure Prophylaxis of Anthrax Disease. CYFENDUS - Anthrax | Not yet recruiting | Emergent BioSolutions | 250 | 2035-11-01 | 2025-12-08 | |
| A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Inhalational Anthrax Patients AIGIV - Inhalational Anthrax | Not yet recruiting | Emergent BioSolutions | 100 | 2027-05-30 | 2026-02-06 | |
| Safety, Tolerability and PK of Intravenous (IV) ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers ETI-204, Ciprofloxacin - Inhalational Anthrax | Phase 1 | Completed | Elusys Therapeutics | 40 | 2013-10-29 | 2019-04-16 |
| Intramuscular Dose-Escalation Study With ETI-204 in Adult Volunteers ETI-204, Placebo - Inhalational Anthrax | Phase 1 | Completed | Elusys Therapeutics | 36 | 2013-07-26 | 2019-05-06 |
| Safety, Tolerability and PK of Repeat Administration of Intravenous ETI-204 in Adult Volunteers ETI-204, Placebo - Inhalational Anthrax | Phase 1 | Completed | Elusys Therapeutics | 70 | 2013-07-23 | 2019-05-14 |
| Safety, Tolerability, and PK of a Single Intravenous Dose of ETI-204 in Adult Volunteers ETI-204, Placebo - Inhalational Anthrax | Phase 1 | Completed | Elusys Therapeutics | 280 | 2013-07-09 | 2019-04-08 |
| Safety and Pharmacokinetic Study of Anthrax Immune Globulin Derived From Human Serum NP-015 - Symptoms of Inhalational Anthrax | Phase 1 | Completed | Emergent BioSolutions | 92 | 2007-07-01 | 2024-03-15 |
Anthrax (4) · Bacterial Infections (1) · Cutaneous anthrax (1) · Gastrointestinal anthrax (1)
Bacillaceae Infections (4) · Bacterial Infections and Mycoses (4) · Gram-Positive Bacterial Infections (4) · Infections (4) · Bacterial Infections (3)
obiltoxaximab (4) · Anthrax Immune Globulin Intravenous (2) · Ciprofloxacin (1)
Elusys Therapeutics (4) · Emergent BioSolutions (3)
United States (5)
Alex King, MD (2) · David Mathews, MD (2) · Alan S Marion, MD, PhD (1) · Brandon Essink, MD (1) · Debra Mandarino, MD (1) · H. Frank Farmer, PhD, MD (1) · Jolene Berg, MD (1) · Lori Sieboldt, MD (1)